Akebia Therapeutics
AKBA
AKBA
94 hedge funds and large institutions have $210M invested in Akebia Therapeutics in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
20% more capital invested
Capital invested by funds: $176M → $210M (+$34.5M)
18% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 28
9% more funds holding
Funds holding: 86 → 94 (+8)
Holders
94
Holding in Top 10
2
Calls
$1.24M
Puts
$828K
Top Buyers
| 1 | +$4.97M | |
| 2 | +$3.3M | |
| 3 | +$2.89M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.05M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$694K |
Top Sellers
| 1 | -$6.94M | |
| 2 | -$2.83M | |
| 3 | -$2.71M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$1.18M |
| 5 |
SIM
Spark Investment Management
New York
|
-$469K |